Regulatory PathRegulatory requirements compared

Active substance

Isoprenaline

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
Vascorin0.2 mg/mlSolution for injection/infusion · Intravenous use1 VialSAR 237.20Generic · PrescriptionALPHA PHARMA INDUSTRYValid
Vascorin0.2 mg/mlSolution for injection/infusion · Intravenous use5 VialSAR 118.60Generic · PrescriptionALPHA PHARMA INDUSTRYValid
ISOPROTERENOL HCL EMERG.1:5000 SYRINGSolution for injection · Intravenous use1 Pre-filled syringeSAR 22.65NCE · PrescriptionHOSPIRA INCWithdrawn by MAH · Not Marketed
ISOPROTERENOL1:5000 ADDIT EMER.SYRINGSolution for injection · Intravenous use1 Pre-filled syringeSAR 21.05NCE · PrescriptionHOSPIRA INCWithdrawn by MAH · Not Marketed

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
ISOPROTERENOL HYDROCHLORIDE0.2MG/MLinjectable · injectionNEXUSPrescription2 Aug 2017
ISOPROTERENOL HYDROCHLORIDE0.2MG/MLinjectable · injectionAMPHASTAR PHARMS INCPrescription18 Jun 2018
ISOPROTERENOL HYDROCHLORIDE0.2MG/MLinjectable · injectionAMNEALPrescription17 Oct 2018
ISOPROTERENOL HYDROCHLORIDE0.2MG/MLinjectable · injectionMICRO LABSPrescription16 Feb 2021
ISOPROTERENOL HYDROCHLORIDE0.2MG/MLinjectable · injectionJ MOLNERPrescription19 May 2021
ISOPROTERENOL HYDROCHLORIDE0.2MG/MLinjectable · injectionAVET LIFESCIENCESPrescription19 Nov 2021
ISOPROTERENOL HYDROCHLORIDE0.2MG/MLinjectable · injectionPENN LIFEPrescription20 Sep 2022
ISOPROTERENOL HYDROCHLORIDE0.2MG/MLinjectable · injectionHIKMA PHARMSPrescription26 Apr 2023
ISOPROTERENOL HYDROCHLORIDE0.2MG/MLinjectable · injectionSOMERSET THERAPS LLCPrescription6 Aug 2024
ISOPROTERENOL HYDROCHLORIDE0.2MG/MLinjectable · injectionGLANDPrescription3 Oct 2024
ISOPROTERENOL HYDROCHLORIDE0.2MG/MLinjectable · injectionDEVA HOLDING ASPrescription10 Dec 2025
ISOPROTERENOL HYDROCHLORIDE0.2MG/MLinjectable · injectionASPIROPrescription18 May 2026
ISUPREL10MG; 15MGtablet · rectal, sublingualSANOFI AVENTIS USDiscontinued19 Feb 1948
MEDIHALER-ISO0.08MG/INHaerosol, metered · inhalation3MDiscontinued9 Mar 1956
ISOPROTERENOL HYDROCHLORIDE0.12MG/INHaerosol, metered · inhalation3MDiscontinued9 Mar 1956
ISUPREL0.2MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**injectable · injectionBAUSCHDiscontinued25 May 1956
ISOPROTERENOL HYDROCHLORIDE0.02MG/MLinjectable · injectionHOSPIRADiscontinued15 Nov 1974
ISOPROTERENOL HYDROCHLORIDE0.2MG/MLinjectable · injectionBAXTER HLTHCAREDiscontinued15 Nov 1974
ISOPROTERENOL HYDROCHLORIDE0.2MG/MLinjectable · injectionHOSPIRADiscontinued15 Jul 1975
ISOPROTERENOL HYDROCHLORIDE0.2MG/MLinjectable · injectionINTL MEDICATIONDiscontinued6 Jan 1976
ISOPROTERENOL HYDROCHLORIDE0.2MG/MLinjectable · injectionCIPLADiscontinued12 Jun 2018
ISOPROTERENOL HYDROCHLORIDE0.2MG/MLinjectable · injectionCIPLADiscontinued28 Jun 2019
ISOPROTERENOL HYDROCHLORIDE0.2MG/MLinjectable · injectionEUGIA PHARMADiscontinued9 Feb 2021
ISOPROTERENOL HYDROCHLORIDE0.2MG/MLinjectable · injectionPHARMOBEDIENTDiscontinued6 Sep 2022
ISOPROTERENOL HYDROCHLORIDE0.2MG/MLinjectable · injectionAM REGENTDiscontinued19 Oct 2022

14 more — full table

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
ISOPROTERENOL HYDROCHLORIDE INJECTION USP008976390.2 MG / MLSOLUTION · SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULARSANDOZ CANADA INCORPORATED
ISOPROTERENOL HYDROCHLORIDE INJECTION USP025026150.2 MG / MLSOLUTION · SUBCUTANEOUS; INTRAMUSCULAR; INTRAVENOUSMARCAN PHARMACEUTICALS INC
ISOPROTERENOL HYDROCHLORIDE INJECTION USP025026231 MG / 5 MLSOLUTION · SUBCUTANEOUS; INTRAMUSCULAR; INTRAVENOUSMARCAN PHARMACEUTICALS INC

Safety signals and safety-related labeling changes

All safety entries for isoprenaline →

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.